Tag
By CreakyStaff
Exciting news for Australians with chronic plaque psoriasis. Two breakthrough treatments have been added to the PBS, bringing fresh possibilities for those with this challenging condition.
By CreakyStaff
Australian children with juvenile idiopathic arthritis may soon have a new treatment option. Here’s how you can help us get this medication subsidised through the Pharmaceutical Benefits Scheme.
By CreakyStaff
Were you transitioned to another medicine during the tocilizumab (Actemra®) shortage? Now that it is available again, you can speak with your rheumatologist about your ongoing treatment options.
By CreakyStaff
Do you use Orencia to treat your inflammatory arthritis? Have you been affected by the current supply shortage? Here are the options available to you.
MyPsA is a new online hub designed to give people with psoriatic arthritis access to tailored information about their condition and much more.
By CreakyStaff
Put mismatched socks to good use and protect your joints with these smart hacks to reduce arthritis pain and make chores easier
By CreakyStaff
How can Australians with autoimmune arthritis access a COVID-19 vaccine? Learn more about your eligibility and the evidence you will need to provide.
By CreakyStaff
This chronic inflammatory arthritis can have many different symptoms, which is why it’s so easy to misdiagnose — and miss, say rheumatologists.
What will the current COVID-19 vaccine candidates mean for Australians with autoimmune conditions? Can we take them? When will we get them?
Ixekizumab (Taltz®) is a new treatment option for Australians with ankylosing spondylitis - a chronic form of arthritis that affects the spine and pelvis.
By 
